no edit summary
Line 18: Line 18:  
*Tertiary damage (cf. burn injuries) is indicative of euthanasia  
 
*Tertiary damage (cf. burn injuries) is indicative of euthanasia  
   −
==Development of ''Lucilia serricata'' in hours (Cousqueur 2006)==
+
==Development of ''Lucilia serricata'' in hours (Cousquer 2006)==
 
{| border="2" align="center" cellspacing="0" cellpadding="4" rules="all"; border-collapse:collapse;empty-cells:show"
 
{| border="2" align="center" cellspacing="0" cellpadding="4" rules="all"; border-collapse:collapse;empty-cells:show"
 
|+  
 
|+  
Line 80: Line 80:  
*Suturing dressings in place
 
*Suturing dressings in place
 
*Granuflex or Duoderm
 
*Granuflex or Duoderm
 +
 
(See Cousquer 2006)
 
(See Cousquer 2006)
   Line 112: Line 113:     
Cyromazine (Rearguard®; Novartis) is licensed for use in rabbits as a preventative – it prevents the moult from L1 to L2 and has a ten week duration of action.
 
Cyromazine (Rearguard®; Novartis) is licensed for use in rabbits as a preventative – it prevents the moult from L1 to L2 and has a ten week duration of action.
 +
 +
==References==
 +
*Cousquer, G. (2006) Veterinary care of rabbits with myiasis In Practice 28 342 – 349
 +
*Okerman, L. (1994) Diseases of Domestic Rabbits. Blackwell Scien¬tific Publications 2nd Edition
 
[[Category:Diseases_and_Disorders_-_Rabbit]]
 
[[Category:Diseases_and_Disorders_-_Rabbit]]
Author
2,954

edits